Holi Secures €3 Million to Expand Its AI-Human Digital Health Clinic
Warsaw-based HealthTech startup Holi has raised €3 million in a seed round led by 4growth VC, with participation from YZR Capital and Heartfelt Capital. The new capital will accelerate the company’s mission to tackle the global metabolic disease epidemic, starting with obesity by combining AI-powered systems with human empathy in digital healthcare.
With this funding, Holi plans to expand into new international markets, advance its AI-human care platform and extend its model into additional health verticals beyond obesity. The startup also aims to deepen partnerships across clinics, payers and pharma, laying the foundation for a scalable, outcomes-driven approach to chronic disease management.
“At Holi, we’re pairing human empathy with AI-powered care to tackle the metabolic disease epidemic, starting with obesity,” the company shared on LinkedIn. “This round lets us expand internationally, advance our AI-human care system and build the partnerships that make healthcare truly effective.”
The Growing Weight of a Global Epidemic
Metabolic diseases, led by obesity and type 2 diabetes, represent one of the most urgent health challenges of the 21st century. According to the World Health Organization, over 800 million people worldwide live with obesity. A number that continues to climb as modern lifestyles strain traditional healthcare systems. In Poland, nearly 60% of adults are overweight, reflecting a broader European and global trend where chronic conditions are outpacing treatment capacity.
Despite growing awareness, current healthcare infrastructures remain reactive rather than preventive. Access to specialized care is limited, while fragmented systems fail to deliver personalized, continuous support.
Holi’s founders recognized that solving this crisis required more than digital convenience. It required rebuilding the clinical model around sustained, data-driven engagement. The result is a fully digital metabolic health clinic that merges AI automation with human medical expertise, creating a system capable of addressing both the biological and behavioral dimensions of obesity.

Inside Holi: A Modern Digital Metabolic Clinic
Holi describes itself as a “modern, fully digital metabolic health clinic” dedicated to helping patients achieve sustainable health outcomes through comprehensive diagnosis and therapy.
The company’s platform connects users with doctors, dietitians and psychologists who coordinate care using AI-driven insights. The system tracks patient progress, detects metabolic patterns and provides clinicians with predictive guidance to personalize interventions.
Unlike many weight-loss apps or telemedicine startups, Holi’s model goes deeper, combining medical oversight with AI-assisted behavioral insights and modern pharmacotherapy, including the use of GLP-1 analogues such as semaglutide, which are becoming game-changers in obesity treatment.
The result is a hybrid model where algorithms help scale precision, but empathy remains central. AI monitors patient data, while clinicians maintain the relationship and trust necessary for long-term adherence. This approach allows Holi to serve as a complete digital clinic rather than a coaching app, one capable of diagnosing, prescribing, and managing complex metabolic conditions remotely and responsibly.
Funding the Next Phase of Growth
The €3 million seed round marks a significant milestone in Holi’s journey and signals growing investor confidence in the European digital health sector. The €3 million capital will be used to accelerate three main initiatives:
- International expansion into new European markets, extending Holi’s reach beyond Poland.
- Enhancement of its AI-human care system, further personalizing patient pathways and improving outcome tracking.
- Extension into new verticals, addressing related metabolic and chronic conditions beyond obesity.
In addition, Holi plans to build strategic partnerships with clinics, payers and pharmaceutical companies to integrate its care platform into broader healthcare ecosystems. As 4growth VC noted in its announcement, Holi represents a new generation of digital health startups, combining clinical rigor with scalable, data-centric design.

Why Does Holi’s Model Stand Out ?
The digital health market has exploded in recent years, but few startups have succeeded in bridging the gap between consumer wellness tools and clinically validated healthcare delivery. Holi sits squarely at that intersection.
Unlike weight-loss apps focused on calorie counting or coaching, Holi operates with medical oversight and measurable health outcomes. It leverages AI to improve efficiency without losing the “human touch” that healthcare demands.
This is especially important in metabolic care, where long-term behavioral change and psychological support are as critical as medical intervention. Holi’s AI modules can predict relapse risk, suggest personalized communication from clinicians and automate parts of follow-up while maintaining empathy and accountability. It’s a model that not only enhances patient engagement but also helps clinicians manage larger caseloads effectively, critical for scaling chronic disease treatment amid growing demand.
The Broader Market Context
Globally, the digital chronic care management market is expected to exceed $30 billion by 2030, driven by rising metabolic disorders and advancements in telemedicine and AI diagnostics. European HealthTech startups are particularly well positioned, benefiting from strong public healthcare frameworks and growing openness to digital therapeutics. Poland, in particular, has become a regional hub for HealthTech innovation, with startups like Holi leading the charge.
Holi’s approach also aligns with a broader shift toward outcomes-based care, where success is measured not by the number of consultations but by improved patient health metrics. This aligns well with the priorities of insurers and national health systems seeking to contain long-term healthcare costs.
Strengths and Considerations of the polish based startup “Holi”
Holi’s greatest strength lies in its hybrid model that fuses scalable AI systems with human clinicians. This allows the company to deliver both precision and empathy, two qualities often missing from purely digital platforms.
Its early traction in Poland, strong investor backing, and clinically integrated approach make it well-positioned to expand across Europe. The company’s medical credibility, combined with its modern product design, differentiates it in a crowded market of consumer-oriented health apps.
Still, Holi will need to navigate the regulatory complexities of cross-border telemedicine and medication management as it expands internationally. Ensuring consistent medical standards and privacy compliance across multiple jurisdictions will be key to sustainable growth.
The Road Ahead: Expanding Digital Empathy in Healthcare
With fresh funding and growing momentum, Holi is entering a pivotal phase, expanding beyond its home market and evolving from a digital obesity clinic into a comprehensive metabolic health ecosystem. The company plans to extend its AI-human care framework into new chronic conditions, deepen partnerships with insurers and pharma and continue investing in precision diagnostics that bridge human judgment and machine learning.
At the heart of this evolution is a belief that technology should amplify empathy, not replace it. Holi’s model reflects a future where healthcare isn’t just virtual. It is personal, adaptive and intelligently connected.
As Europe confronts a rising tide of chronic disease, Holi stands as an example of how HealthTech can balance science, software and compassion to deliver lasting change. By redefining how care is delivered and how outcomes are measured. Holi is building more than a digital clinic. It’s building a new foundation for the era of intelligent, humane medicine.

